MCRB - Seres Therapeutics, Inc.

QQQ $ 432.34 $ 4.36 (1.02 %)

DIA $ 383.02 $ 2.21 (0.58 %)

SPY $ 509.62 $ 1.45 (0.29 %)

TLT $ 88.24 $ -0.03 (-0.03 %)

GLD $ 216.46 $ -0.82 (-0.38 %)

Previous Close

$ 0.7427

Open

$ 0.74

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.74 - $ 0.80

52 Week Range

$ 0.54 - $ 6.65

Volume

3,441,105

Average Volume

Market Cap

95.07M

Beta (5Y Monthly)

$ 1.10

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-05-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	03-07-2023	12-31-2022	10-K
6	11-02-2022	09-30-2022	10-Q
7	08-03-2022	06-30-2022	10-Q
8	05-04-2022	03-31-2022	10-Q
9	03-01-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-03-2021	06-30-2021	10-Q
12	05-04-2021	03-31-2021	10-Q
13	03-02-2021	12-31-2020	10-K
14	11-09-2020	09-30-2020	10-Q
15	07-28-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	03-02-2020	12-31-2019	10-K
18	11-05-2019	09-30-2019	10-Q
19	08-06-2019	06-30-2019	10-Q
20	05-02-2019	03-31-2019	10-Q
21	03-06-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-02-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	03-08-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-03-2017	06-30-2017	10-Q
28	05-04-2017	03-31-2017	10-Q
29	03-16-2017	12-31-2016	10-K
30	11-10-2016	09-30-2016	10-Q
31	08-11-2016	06-30-2016	10-Q
32	05-16-2016	03-31-2016	10-Q
33	03-14-2016	12-31-2015	10-K
34	11-12-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Seres Therapeutics Concludes Enrollment In...
04/09/2024 11:11:45

Seres Therapeutics Announced That On March...
03/28/2024 11:26:45

Oppenheimer Maintains Outperform on Seres ...
03/06/2024 13:59:45

Oppenheimer analyst Jeff Jones maintains Seres Therapeutics (NASDAQ:MCRB) with a Outperform and lowers the price target from...

emerson-electric-to-rally-more-than-19-here-are-10-top-analyst-forecasts-for-wednesday

Emerson Electric To Rally More Than 19%? H...
03/06/2024 13:00:40

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Chardan Capital Maintains Buy on Seres The...
03/06/2024 12:38:27

Chardan Capital analyst Keay Nakae maintains Seres Therapeutics (NASDAQ:MCRB) with a Buy and lowers the price target from $1...

Seres' $128M In Cash Balance, Planned Savi...
03/05/2024 12:07:11

Seres Therapeutics FY GAAP EPS $(0.89) Bea...
03/05/2024 12:04:40

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(0.89) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For March 5, 2024
03/05/2024 10:00:02

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

Seres Therapeutics's Earnings: A Preview
03/04/2024 16:02:42

Seres Therapeutics Announced That Marella ...
02/26/2024 12:09:28

Seres Therapeutics Reports Inducement Gran...
01/17/2024 12:10:15

Seres Therapeutics, Inc. (NASDAQ:MCRB) ("Seres" or the "Company"), a leading microbiome therapeutics company, t...

Oppenheimer Maintains Outperform on Seres ...
01/16/2024 15:37:32

Oppenheimer analyst Jeff Jones maintains Seres Therapeutics (NASDAQ:MCRB) with a Outperform and lowers the price target from...

why-is-microbiome-based-seres-therapeutics-stock-trading-higher-today

Why Is Microbiome-Based Seres Therapeutics...
01/09/2024 17:12:41

Seres Therapeutics Inc (NASDAQ: MCRB) received FDA Fast Track Designation for SER-155, an investigational oral, cultivated micr...

dow-tumbles-over-200-points-us-trade-gap-narrows-in-november

Dow Tumbles Over 200 Points; US Trade Gap ...
01/09/2024 14:40:00

U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market openin...

Seres Therapeutics shares are trading high...
01/09/2024 14:08:20

Market-Moving News for January 9th
01/09/2024 13:38:35

JNPR: 25% | Juniper Networks Surges Over 20% As Hewlett Packard Enterprise Reportedly Nears $13B Acquisition Deal MCRB: 44% | ...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
01/09/2024 13:06:02

Seres Therapeutics Receives FDA Fast Track...
01/09/2024 12:14:10

SER-155 Phase 1b placebo-controlled Cohort 2 data readout anticipated in third quarter of 2024

Seres Therapeutics Announces Vowst Prelimi...
01/09/2024 12:11:49

Significant adoption of VOWST since commercial launch in June 2023 through year-end 2023 with 2,833 patient enrollment forms re...

Reported Earlier, Seres Therapeutics To Pr...
12/08/2023 07:45:30